Plasmapheresis
| Zeile 11: | Zeile 11: | ||
{{tp|p=32389697|t=ä. Plasmapheresis treatment in COVID-19?related autoimmune meningoencephalitis: Case series |pdf=|usr=}} | {{tp|p=32389697|t=ä. Plasmapheresis treatment in COVID-19?related autoimmune meningoencephalitis: Case series |pdf=|usr=}} | ||
{{tp|p=32393681|t=2020. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab.|pdf=|usr=007}} | {{tp|p=32393681|t=2020. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab.|pdf=|usr=007}} | ||
| − | + | {{tp|p=32397847|t=2020. Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens.|pdf=|usr=008}} | |
| − | + | {{tp|p=32470601|t=2020. Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.|pdf=|usr=008}} | |
| − | + | {{tp|p=32432784|t=2020. Editorial - High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients.|pdf=|usr=008}} | |
| − | + | {{tp|p=32283154|t=2020. Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19.|pdf=|usr=008}} | |
| − | + | {{tp|p=32426229|t=2020. Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia.|pdf=|usr=008}} | |
Version vom 27. Juni 2020, 20:22 Uhr
Plamapheresis, Immunoadsorption, IVIG, MARS, Cytosorb,
32247038 2020. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
32241301 2020. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19
C7118608 ä. A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System
32391669 2020. [Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab].
32359878 2020. Application of plasma exchange in association with higher dose CVVH in Cytokine Storm Complicating COVID-19
32353740 2020. Serum albumin-mediated strategy for the effective targeting of SARS-CoV-2
32258207 2020. High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
32361195 ä. SARS-CoV-2 infection complicated by inflammatory syndrome Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?
32389697 ä. Plasmapheresis treatment in COVID-19?related autoimmune meningoencephalitis: Case series
32393681 2020. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab.
32397847 2020. Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens.
32470601 2020. Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.
32432784 2020. Editorial - High dose intravenous immunoglobulins as a therapeutic option for COVID-19 patients.
32283154 2020. Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19.
32426229 2020. Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia.
32510799 2020. The Application Of Plasmapheresis For Covid-19 Patients.
32501607 2020. Selective C-reactive protein (CRP) apheresis for Covid-19 patients suffering from organ damage.
